| Invasive coronary angiography*
|
1,640 (70.2%) |
1,572 (72.8%) |
68 (38.4%) |
| Percutaneous coronary intervention*
|
1,341 (57.4%) |
1,294 (59.9%) |
47 (26.6%) |
| Temporary pacemaker |
210 (9.0%) |
188 (8.7%) |
22 (12.4%) |
| Conventional pacemaker |
111 (4.7%) |
108 (5.0%) |
3 (1.7%) |
| Implantable cardioverter defibrillator |
15 (0.6%) |
15 (0.7%) |
0 |
| Cardiac resynchronization therapy and pacemaker or defibrillator |
11 (0.5%) |
10 (0.5%) |
1 (0.6%) |
| Ablation for tachycardia |
88 (3.8%) |
88 (3.8%) |
0 |
| Left atrial appendage closure |
31 (1.3%) |
31 (1.4%) |
0 |
| Transcatheter aortic implantation or balloon aortic valvuloplasty |
51 (2.2%) |
48 (2.2%) |
3 (1.7%) |
| Interventional therapy for congenital heart disease |
21 (0.9%) |
20 (0.9%) |
1 (0.6%) |
| Extracorporeal membrane oxygenation |
4 (0.2%) |
2 (0.1%) |
2 (1.1%) |
| Intra-aortic balloon pump*
|
87 (3.7%) |
56 (2.6%) |
31 (17.5%) |
| Inotropes or vasopressors*
|
312 (13.4%) |
175 (8.1%) |
137 (77.4%) |
| Arterial line*
|
407 (17.4%) |
284 (13.1%) |
123 (69.5%) |
| Central venous catheter*
|
227 (9.7%) |
130 (6.0%) |
97 (54.8%) |
| Continuous renal replacement treatment*
|
59 (2.5%) |
32 (1.5%) |
27 (15.3%) |
| Mechanical ventilation*
|
316 (13.5%) |
175 (8.1%) |
141 (79.7%) |
